Principal Pharmacovigilance Specialist
CurrentPatient Safety.Responsible for surveillance of product in development phase.Collaboration with safety CRO and clinical CRO.Input to and evaluation of clinical CRO selection.Preparing and driving internal safety committee meetings. Involved in interpretation and presentation of phase 1 data. Input to phase 1 and 2 trial outline, protocol and informed consent form in collaboration with clinical CRO. Presenting at investigator meeting. Driving creation/update of internal risk overview, minimum mandatory safety text (MMST), Development Safety Update Report (DSUR).Timely input for Investigator’s Brochure (IB), Clinical Overview, Clinical Trial Applications (CTAs)/Investigational New Drug (IND) Applications.Co-organising social events.